HRP20090617T1 - Protutumorska kombinacija koja sadrži substituirane akriloil distamicinske derivate i protutijela koja inhibiraju čimbenike rasta ili njihove receptore - Google Patents

Protutumorska kombinacija koja sadrži substituirane akriloil distamicinske derivate i protutijela koja inhibiraju čimbenike rasta ili njihove receptore Download PDF

Info

Publication number
HRP20090617T1
HRP20090617T1 HR20090617T HRP20090617T HRP20090617T1 HR P20090617 T1 HRP20090617 T1 HR P20090617T1 HR 20090617 T HR20090617 T HR 20090617T HR P20090617 T HRP20090617 T HR P20090617T HR P20090617 T1 HRP20090617 T1 HR P20090617T1
Authority
HR
Croatia
Prior art keywords
group
formula
combination according
amino
treatment
Prior art date
Application number
HR20090617T
Other languages
English (en)
Croatian (hr)
Inventor
Pesenti Enrico
Ciomei Marina
Cristina Geroni Maria
Original Assignee
Nerviano Medical Sciences S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerviano Medical Sciences S.R.L. filed Critical Nerviano Medical Sciences S.R.L.
Publication of HRP20090617T1 publication Critical patent/HRP20090617T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
HR20090617T 2005-04-08 2006-03-29 Protutumorska kombinacija koja sadrži substituirane akriloil distamicinske derivate i protutijela koja inhibiraju čimbenike rasta ili njihove receptore HRP20090617T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05102792 2005-04-08
PCT/EP2006/061153 WO2006108763A1 (en) 2005-04-08 2006-03-29 Antitumor combination comprising substituted acryloyl distamycin derivatives and antibodies inhibiting growth factors or their receptors

Publications (1)

Publication Number Publication Date
HRP20090617T1 true HRP20090617T1 (hr) 2009-12-31

Family

ID=36624474

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090617T HRP20090617T1 (hr) 2005-04-08 2006-03-29 Protutumorska kombinacija koja sadrži substituirane akriloil distamicinske derivate i protutijela koja inhibiraju čimbenike rasta ili njihove receptore

Country Status (20)

Country Link
US (1) US20090074757A1 (pt)
EP (1) EP1868599B1 (pt)
JP (1) JP2008534649A (pt)
CN (1) CN101141955A (pt)
AT (1) ATE447950T1 (pt)
AU (1) AU2006233856A1 (pt)
BR (1) BRPI0607499A2 (pt)
CA (1) CA2598578A1 (pt)
CY (1) CY1109782T1 (pt)
DE (1) DE602006010349D1 (pt)
DK (1) DK1868599T3 (pt)
EA (1) EA011574B1 (pt)
ES (1) ES2335805T3 (pt)
HR (1) HRP20090617T1 (pt)
MX (1) MX2007010525A (pt)
PL (1) PL1868599T3 (pt)
PT (1) PT1868599E (pt)
RS (1) RS51231B (pt)
SI (1) SI1868599T1 (pt)
WO (1) WO2006108763A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2831110T3 (en) * 2012-03-30 2018-08-06 Univ California Anti-EMP2 therapy to reduce cancer stem cells
WO2013155346A1 (en) 2012-04-11 2013-10-17 The Regents Of The University Of California Diagnostic tools for response to 6-thiopurine therapy
CN109966499A (zh) * 2019-04-25 2019-07-05 苏州大学 协同增效的抗乳腺癌转移药物组合物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165922A (en) * 1990-05-22 1992-11-24 Bristol-Myers Squibb Company Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy
US6150508A (en) * 1996-03-25 2000-11-21 Northwest Biotherapeutics, Inc. Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
ES2263835T3 (es) * 2002-01-02 2006-12-16 Nerviano Medical Sciences S.R.L. Terapia combinada contra tumores que comprende derivados de distamicina acriloil sustituidos e inhibidores proteina quinasa (serina/treonina quinasa).
KR100968657B1 (ko) * 2002-04-02 2010-07-06 네르비아노 메디칼 사이언시스 에스.알.엘. 치환된 아크릴로일 디스타마이신 유도체 및 방사선요법을포함하는 조합 종양 치료법

Also Published As

Publication number Publication date
JP2008534649A (ja) 2008-08-28
WO2006108763A1 (en) 2006-10-19
CA2598578A1 (en) 2006-10-19
CY1109782T1 (el) 2014-09-10
PL1868599T3 (pl) 2010-04-30
DE602006010349D1 (de) 2009-12-24
EP1868599B1 (en) 2009-11-11
AU2006233856A1 (en) 2006-10-19
EP1868599A1 (en) 2007-12-26
RS51231B (sr) 2010-12-31
SI1868599T1 (sl) 2010-01-29
EA200702197A1 (ru) 2008-02-28
CN101141955A (zh) 2008-03-12
US20090074757A1 (en) 2009-03-19
EA011574B1 (ru) 2009-04-28
BRPI0607499A2 (pt) 2009-06-13
ATE447950T1 (de) 2009-11-15
PT1868599E (pt) 2010-01-26
ES2335805T3 (es) 2010-04-05
DK1868599T3 (da) 2010-02-15
MX2007010525A (es) 2008-01-16

Similar Documents

Publication Publication Date Title
WO2021012049A8 (en) Substituted 2-morpholinopyridine derivatives as atr kinase inhibitors
CO6231028A2 (es) Compuestos y composiciones como inhibidores de la proteina quinasa
CO5721006A2 (es) Derivados de pirazolo-quinazolina, proceso para su preparacion y su uso como inhibidores de quinasa
TW200643015A (en) 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives
HRP20090533T1 (hr) Derivati indolila kao modulatori x-receptora
AR077849A2 (es) Compuestos y composiciones como inhibidores de proteina quinasa
ME02815B (me) Biciklična heterociklična jedinjenja kao inhibitori protein tirozin kinaze
NO20084302L (no) 2-(syklisk amino)-pyrimidonderivater som TPK1-inhibitorer
HRP20110156T1 (hr) Monociklički heterocikli kao inhibitori kinaze
ME02373B (me) Biciklična heterociklična jedinjenja kao inhibitori protein tirozin kinaze
RU2007134380A (ru) Антибактериальные производные пиперидина
TW200740820A (en) Fused heterocyclic derivatives and use thereof
RU2015104342A (ru) Ингибиторы рецептора фактора роста фибробластов
AR083339A1 (es) Compuestos de quinazolina como bloqueadores de los canales de sodio
WO2006109075A3 (en) Hydroxybenzamide derivatives and their use as inhibitors of hsp90
NZ590355A (en) Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
RU2009115784A (ru) Производные пиразоло[1,5-а]пиримидина и их применение в медицине
CY1116183T1 (el) Πιπεραζινοδιονες ως ανταγωνιστες υποδοχεα οξυτοκινης
PE20090216A1 (es) Compuestos triazolil aminopirimidina
MX2009007954A (es) Derivado de heterocicliden-n-(aril) acetamida.
ATE501141T1 (de) Kondensierte bizyklisch substituierte amine als histamin 3 rezeptor liganden
RU2013130256A (ru) Новые циклоспориновые производные для лечения и предупреждения вирусных инфекций
AR051638A1 (es) Compuestos de piperidinilo y su uso para tratar desordenes de respuesta al bloqueo de los canales de calcio tipo n
MX2007007428A (es) Compuestos heterociclicos, antagonistas de ccr2b.
EA201000101A1 (ru) Производные пиримидина 934